Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Infect Prev Pract ; 6(3): 100371, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38855736

ABSTRACT

Purpose: Until now, the Hospitalization Rate (HR) served as an indicator (among others) for the COVID-19 associated healthcare burden. To ensure that the HR accomplishes its full potential, hospitalizations caused by COVID-19 (primary cases) and hospitalizations of patients with incidental positive SARS-CoV-2 test results (incidental cases) must be differentiated. The aim of this study was to synthesize the existing evidence on differentiation criteria between hospitalizations of primary cases and incidental cases. Methods: An online survey of the members of the German Network University Medicine (NUM) was conducted. Additionally, senior clinicians with expertise in COVID-19 care were invited for qualitative, semi-structured interviews. Furthermore, a rapid literature review was undertaken on publications between 03/2020 and 12/2022. Results: In the online survey (n=30, response rate 56%), pneumonia and acute upper respiratory tract infections were the most indicative diagnoses for a primary case. In contrast, malignant neoplasms and acute myocardial infarctions were most likely to be associated with incidental cases. According to the experts (n=6), the diagnosis, ward, and type of admission (emergency or elective), low oxygen saturation, need for supplemental oxygen, and initiation of COVID-19 therapy point to a primary case. The literature review found that respiratory syndromes and symptoms, oxygen support, and elevated levels of inflammatory markers were associated with primary cases. Conclusion: There are parameters for the differentiation of primary from incidental cases to improve the objective of the HR. Ultimately, an updated HR has the potential to serve as a more accurate indicator of the COVID-19 associated healthcare burden.

2.
J Hosp Infect ; 146: 125-133, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38295904

ABSTRACT

BACKGROUND: Surveillance is an acknowledged method to decrease nosocomial infections, such as surgical site infections (SSIs). Electronic healthcare records create the opportunity for automated surveillance. While approaches for different types of surgeries and indicators already exist, there are very few for obstetrics and gynaecology. AIM: To analyse the sensitivity and workload reduction of semi-automated surveillance in obstetrics and gynaecology. METHODS: In this retrospective, single-centre study at a 1438-bed tertiary care hospital in Germany, semi-automated SSI surveillance using the indicators 'antibiotic prescription', 'microbiological data' and 'administrative data' (diagnosis codes, readmission, post-hospitalization care) was compared with manual analysis and categorization of all patient files. Breast surgeries (BSs) conducted in 2018 and caesarean sections (CSs) that met the inclusion criteria between May 2013 and December 2019 were included. Indicators were analysed for sensitivity, number of analysed procedures needed to identify one case, and potential workload reduction in detecting SSIs in comparison with the control group. FINDINGS: The reference standard showed nine SSIs in 416 BSs (2.2%). Sensitivities for the indicators 'antibiotic prescription', 'diagnosis code', 'microbiological sample taken', and the combination 'diagnosis code or microbiological sample' were 100%, 88.9%, 66.7% and 100%, respectively. The reference standard showed 54 SSIs in 3438 CSs (1.6%). Sensitivities for the indicators 'collection of microbiological samples', 'diagnosis codes', 'readmission/post-hospitalization care', and the combination of all indicators were 38.9%, 27.8%, 85.2% and 94.4%, respectively. CONCLUSIONS: Semi-automated surveillance systems may reduce workload by maintaining high sensitivity depending on the type of surgery, local circumstances and thorough digitalization.


Subject(s)
Cross Infection , Gynecology , Pregnancy , Female , Humans , Retrospective Studies , Infection Control , Cross Infection/microbiology , Surgical Wound Infection/epidemiology , Surgical Wound Infection/prevention & control , Surgical Wound Infection/diagnosis , Anti-Bacterial Agents/therapeutic use
3.
Biochemistry ; 37(37): 12884-91, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9737867

ABSTRACT

Arachidonic acid is the rate-limiting substrate in the biosynthesis of leukotrienes in activated neutrophils. Liberation of arachidonate from intracellular membranes and uptake of exogenous arachidonate are the two principal mechanisms by which the cell can increase the level of this substrate. We investigated arachidonate uptake and export by using intact polymorphonuclear neutrophils and inside-out plasma membrane vesicles thereof. Here we show that the cellular uptake of arachidonate is energy dependent with an energy of activation (EA) of 10.0 kcal/mol and half-saturated at an arachidonate concentration of 4.8 nmol/mg of cell protein. Protein-facilitated transport of arachidonate across the plasma membrane in either direction is sensitive to proteases, chemical protein modifying reagents, anion transport inhibitors, and, most notably, toward several structurally unrelated leukotriene B4 receptor antagonists with IC50 values in the range of 16-44 microM. The inhibitors did not inhibit the diffusional uptake of methyl arachidonate into neutrophils and inside-out plasma membrane vesicles, indicating that a transport protein is required for the rapid uptake of the free acid but not for the uptake of the ester. Other long-chain fatty acids did compete with the uptake of arachidonate in both assay systems, whereas leukotriene B4 did not. This study documents a novel protein-facilitated transport mechanism for arachidonate in neutrophils, potentially involved in transcellular eicosanoid biosynthesis and sPLA2-mediated arachidonate signaling in neutrophils.


Subject(s)
Arachidonic Acid/blood , Membrane Proteins/blood , Neutrophils/metabolism , Animals , Arachidonic Acid/antagonists & inhibitors , Arachidonic Acid/metabolism , Binding, Competitive , Biological Transport/drug effects , Cell Membrane/metabolism , Diffusion , Endopeptidases/metabolism , Esterification , Fatty Acids/metabolism , Kinetics , Receptors, Leukotriene B4/antagonists & inhibitors , Sulfhydryl Reagents/pharmacology , Swine , Tritium
4.
J Biol Chem ; 272(16): 10601-7, 1997 Apr 18.
Article in English | MEDLINE | ID: mdl-9099707

ABSTRACT

Activated neutrophils release a variety of eicosanoids into the extracellular medium including arachidonic acid, 5-hydroxyicosatetraenoic acid, and leukotriene A4 and B4. In this study, the mechanism of arachidonic acid export has been examined using inside-out plasma membrane vesicles from pig polymorphonuclear leukocytes. Tritiated arachidonic acid associated rapidly with the membrane vesicles and crossed the membrane into the intravesicular space in a time-dependent and saturable manner. Half the maximal influx rate was measured at an arachidonate concentration of 5.7 microM, and a maximal influx velocity of 3.0 nmol/mg x min was determined at pH 6.8. Influx into vesicles was sensitive to a number of common anion transport inhibitors including pentachlorophenol, phloretin, diiodosalicylic acid, and quercetin as well as to the proteases trypsin and Pronase, suggesting a protein-dependent process. Furthermore, influx was temperature-sensitive with an energy of activation of 11.6 kcal/mol. Varying extravesicular concentration of ATP, Na+, or K+ had no impact on arachidonate influx, whereas changes in pH had a profound effect; optimum transport activity was observed at an extravesicular pH of 6, whereas raising the pH to 9.5 essentially abolished uptake. These results indicate and initially characterize a novel protein-facilitated arachidonate export mechanism in pig neutrophils.


Subject(s)
Arachidonic Acid/blood , Neutrophils/metabolism , Phagosomes/metabolism , Adenosine Triphosphate/pharmacology , Animals , Calorimetry , Cell Fractionation , Ethylmaleimide/pharmacology , Hydroxyeicosatetraenoic Acids/blood , In Vitro Techniques , Kinetics , Leukotriene A4/blood , Leukotriene B4/blood , Neutrophils/drug effects , Neutrophils/ultrastructure , Phagocytosis , Phagosomes/ultrastructure , Phloretin/pharmacology , Potassium/pharmacology , Quercetin/pharmacology , Sodium/pharmacology , Swine , Temperature
5.
Opt Lett ; 14(15): 814-6, 1989 Aug 01.
Article in English | MEDLINE | ID: mdl-19752977

ABSTRACT

A new type of star coupler for single-mode optical fibers is proposed. The geometrical configuration of the coupler is intended to be a tapered cylindrical ring structure. A numerical analysis yields the evolution of the light distribution along the coupling region and the spectral characteristics of the coupler. For a star coupler with 8 x 8 ports and a length of 14 mm a spectral width of 90 nm was calculated, if an additional loss of 0.5 dB is tolerated.

SELECTION OF CITATIONS
SEARCH DETAIL
...